PROCEPT BioRobotics Past Earnings Performance
Past criteria checks 0/6
PROCEPT BioRobotics's earnings have been declining at an average annual rate of -25.6%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been growing at an average rate of 69.7% per year.
Key information
-25.6%
Earnings growth rate
73.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 69.7% |
| Return on equity | -37.7% |
| Net Margin | -77.8% |
| Next Earnings Update | 01 May 2024 |
Recent past performance updates
Recent updates
The Price Is Right For PROCEPT BioRobotics Corporation (NASDAQ:PRCT)
Apr 05
US$56.67 - That's What Analysts Think PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Is Worth After These Results
Mar 01Despite Lacking Profits PROCEPT BioRobotics (NASDAQ:PRCT) Seems To Be On Top Of Its Debt
Feb 07Market Participants Recognise PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) Revenues Pushing Shares 26% Higher
Dec 14Is There An Opportunity With PROCEPT BioRobotics Corporation's (NASDAQ:PRCT) 43% Undervaluation?
Feb 27Procept Biorobotics announces $52M debt refinancing
Oct 10Providence announces national contract for PROCEPT Biorobotics Aquabeam Systems
Sep 19Procept BioRobotics Has Resources To Ramp Up Commercialization
Sep 01Procept: Leveraging A Novel Water-Based System For Enlarged Prostate Treatment
May 26Need To Know: Analysts Are Much More Bullish On PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Revenues
May 10PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported, And Analysts Assigned A US$41.00 Price Target
Mar 10Revenue & Expenses BreakdownBeta
How PROCEPT BioRobotics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 136 | -106 | 132 | 48 |
| 30 Sep 23 | 116 | -107 | 121 | 44 |
| 30 Jun 23 | 102 | -105 | 113 | 40 |
| 31 Mar 23 | 85 | -98 | 101 | 35 |
| 31 Dec 22 | 75 | -87 | 89 | 29 |
| 30 Sep 22 | 61 | -77 | 79 | 24 |
| 30 Jun 22 | 50 | -69 | 66 | 22 |
| 31 Mar 22 | 41 | -64 | 59 | 19 |
| 31 Dec 21 | 34 | -60 | 51 | 19 |
| 30 Sep 21 | 28 | -57 | 44 | 18 |
| 30 Jun 21 | 21 | -55 | 39 | 17 |
| 31 Mar 21 | 14 | -53 | 34 | 17 |
| 31 Dec 20 | 8 | -53 | 30 | 16 |
| 31 Dec 19 | 6 | -42 | 29 | 13 |
Quality Earnings: PRCT is currently unprofitable.
Growing Profit Margin: PRCT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: PRCT is unprofitable, and losses have increased over the past 5 years at a rate of 25.6% per year.
Accelerating Growth: Unable to compare PRCT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PRCT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: PRCT has a negative Return on Equity (-37.72%), as it is currently unprofitable.